Mawer Investment Management LTD Has Lifted Its Holding in Novartis Ag (NVS) by $7.71 Million

April 20, 2018 - By Winifred Garcia

Novartis AG (NYSE:NVS) Logo

Mawer Investment Management Ltd increased its stake in Novartis Ag (NVS) by 3.49% based on its latest 2017Q4 regulatory filing with the SEC. Mawer Investment Management Ltd bought 92,908 shares as the company’s stock declined 4.22% with the market. The institutional investor held 2.76 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $231.58M, up from 2.67 million at the end of the previous reported quarter. Mawer Investment Management Ltd who had been investing in Novartis Ag for a number of months, seems to be bullish on the $182.57 billion market cap company. The stock decreased 1.54% or $1.22 during the last trading session, reaching $77.78. About 2.62 million shares traded or 38.49% up from the average. Novartis AG (NYSE:NVS) has risen 5.79% since April 20, 2017 and is uptrending. It has underperformed by 5.76% the S&P500.

Mawer Investment Management Ltd, which manages about $20.93B and $12.09B US Long portfolio, decreased its stake in Telus Corp (NYSE:TU) by 268,445 shares to 4.63 million shares, valued at $175.34 million in 2017Q4, according to the filing. It also reduced its holding in Rogers Communications In (NYSE:RCI) by 652,661 shares in the quarter, leaving it with 4.96 million shares, and cut its stake in Exxon Mobil Corp (NYSE:XOM).

Novartis AG (NYSE:NVS) Ratings Coverage

Among 4 analysts covering Novartis AG Common Stock (NYSE:NVS), 0 have Buy rating, 2 Sell and 2 Hold. Therefore 0 are positive. Novartis AG Common Stock had 5 analyst reports since October 23, 2017 according to SRatingsIntel. As per Wednesday, October 25, the company rating was downgraded by Barclays Capital. Leerink Swann maintained the stock with “Market Perform” rating in Thursday, January 25 report. The stock of Novartis AG (NYSE:NVS) earned “Market Perform” rating by Leerink Swann on Monday, October 23. Cowen & Co maintained Novartis AG (NYSE:NVS) rating on Friday, February 2. Cowen & Co has “Hold” rating and $98.0 target. The rating was downgraded by Bank of America to “Sell” on Wednesday, December 6.

Novartis AG (NYSE:NVS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.